Rojas-Espinosa O, Jiménez-Zamudio L, Arce-Paredes P
Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, México, D.F., Mexico.
Rev Latinoam Microbiol. 1994 Jul-Sep;36(3):213-9.
Lepromatous leprosy in the human being evolves showing a progressive loss of cell mediated immunity (CMI) to the antigens of Mycobacterium leprae (ML). This does not prevent the host to respond with antibodies to the same microorganism. On the other hand, the production of antibodies to the great majority of exogenous antigens results from cell-to-cell interactions that involve the participation of helper T cells. On this ground, a satisfactory explanation for the loss of CMI to M. leprae (which indicates either the loss or inactivation of specific helper T cells), with no effect on the humoral response to the same microorganism (this implying the participation of functional specific helper T cells), was difficult to found. It was not until Mosmann established, in the mouse, the existence of two subpopulations of helper T cells, that a feasible explanation for the apparent immunological paradox observed in leprosy was possible to offer. The work described here, based to a great extent in our experience on murine leprosy, refers to recent concepts concerning this issue.
人类的瘤型麻风病表现为对麻风分枝杆菌(ML)抗原的细胞介导免疫(CMI)逐渐丧失。但这并不妨碍宿主针对同一微生物产生抗体。另一方面,针对绝大多数外源性抗原产生抗体是细胞间相互作用的结果,其中辅助性T细胞参与其中。基于此,对于麻风分枝杆菌CMI丧失(这表明特异性辅助性T细胞丧失或失活)而对同一微生物的体液反应却无影响(这意味着功能性特异性辅助性T细胞参与其中)这一现象,很难找到令人满意的解释。直到莫斯曼在小鼠中证实存在两种辅助性T细胞亚群,才有可能对麻风病中观察到的明显免疫悖论提供一个可行的解释。本文所述工作在很大程度上基于我们对鼠麻风病的经验,涉及有关此问题的最新概念。